Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 249 | 121 | 457 | 366 | 469 |
| Cost of Goods | 183 | 84 | 227 | 127 | 189 |
| Gross Profit | 66 | 37 | 230 | 239 | 280 |
| Operating Expenses | 1,552 | 1,160 | 974 | 968 | 1,172 |
| Operating Income | -1,486 | -1,123 | -744 | -729 | -892 |
| Interest Expense | 4 | 0 | 0 | 0 | 1 |
| Other Income | 3 | -2 | -1 | 7 | 7 |
| Pre-tax Income | -1,487 | -1,125 | -745 | -723 | -885 |
| Net Income Continuous | -1,487 | -1,125 | -745 | -723 | -885 |
| Net Income | $-1,487 | $-1,125 | $-745 | $-723 | $-885 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-1,409 | $-1,075 | $-686 | $-664 | $-831 |